Literature DB >> 18509012

MicroRNA signatures as diagnostic and therapeutic targets.

Scott A Waldman1, Andre Terzic.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18509012     DOI： 10.1373/clinchem.2008.105353

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  18 in total

1.  Applications of microRNA in cancer: Exploring the advantages of miRNA.

Authors:  Scott A Waldman; Andre Terzic
Journal:  Clin Transl Sci       Date:  2009-06       Impact factor: 4.689

2.  MicroRNA-mediated interacting circuits predict hypoxia and inhibited osteogenesis of stem cells, and dysregulated angiogenesis are involved in osteonecrosis of the femoral head.

Authors:  Gour-Shenq Kao; Yuan-Kun Tu; Pei-Hsun Sung; Feng-Sheng Wang; Yu-Der Lu; Chen-Ta Wu; Rio L C Lin; Hon-Kan Yip; Mel S Lee
Journal:  Int Orthop       Date:  2018-04-26       Impact factor: 3.075

3.  MiR-9-5p Down-Regulates PiT2, but not PiT1 in Human Embryonic Kidney 293 Cells.

Authors:  D P Bezerra; M Keasey; J R M Oliveira
Journal:  J Mol Neurosci       Date:  2017-03-16       Impact factor: 3.444

4.  Plasma and synovial fluid microRNAs as potential biomarkers of rheumatoid arthritis and osteoarthritis.

Authors:  Koichi Murata; Hiroyuki Yoshitomi; Shimei Tanida; Masahiro Ishikawa; Kohei Nishitani; Hiromu Ito; Takashi Nakamura
Journal:  Arthritis Res Ther       Date:  2010-05-14       Impact factor: 5.156

5.  Circulating microRNAs, potential biomarkers for drug-induced liver injury.

Authors:  Kai Wang; Shile Zhang; Bruz Marzolf; Pamela Troisch; Amy Brightman; Zhiyuan Hu; Leroy E Hood; David J Galas
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-25       Impact factor: 11.205

Review 6.  A study of microRNAs in silico and in vivo: diagnostic and therapeutic applications in cancer.

Authors:  Scott A Waldman; Andre Terzic
Journal:  FEBS J       Date:  2009-02-25       Impact factor: 5.542

7.  Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer.

Authors:  Qifeng Wang; Zhaohui Huang; Shujuan Ni; Xiuying Xiao; Qinghua Xu; Lisha Wang; Dan Huang; Cong Tan; Weiqi Sheng; Xiang Du
Journal:  PLoS One       Date:  2012-09-06       Impact factor: 3.240

8.  The Role of MicroRNAs in Regulatory T Cells and in the Immune Response.

Authors:  Tai-You Ha
Journal:  Immune Netw       Date:  2011-02-28       Impact factor: 6.303

9.  ANT2 suppression by shRNA restores miR-636 expression, thereby downregulating Ras and inhibiting tumorigenesis of hepatocellular carcinoma.

Authors:  Ji-Young Jang; Young-Sin Lee; Yoon-Kyung Jeon; Kyoungbun Lee; Ja-June Jang; Chul-Woo Kim
Journal:  Exp Mol Med       Date:  2013-01-10       Impact factor: 8.718

10.  MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy.

Authors:  Monika Jung; Hans-Joachim Mollenkopf; Christina Grimm; Ina Wagner; Marco Albrecht; Tobias Waller; Christian Pilarsky; Manfred Johannsen; Carsten Stephan; Hans Lehrach; Wilfried Nietfeld; Thomas Rudel; Klaus Jung; Glen Kristiansen
Journal:  J Cell Mol Med       Date:  2009-02-17       Impact factor: 5.310
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.